-
Mashup Score: 3Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation - 2 month(s) ago
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 63A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - 4 month(s) ago
Learn more about services at Mayo Clinic.
Source: www.mayo.eduCategories: General Medicine News, General HCPsTweet-
Mayo Clinic researchers are looking to immune checkpoint inhibitors plus chemotherapy for recurrent #SmallCellLungCancer. Learn more at https://t.co/4N69odUYVx https://t.co/zqOsohPX5s
-
-
Mashup Score: 11A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - 5 month(s) ago
Learn more about services at Mayo Clinic.
Source: www.mayo.eduCategories: General Medicine News, General HCPsTweet-
Mayo Clinic researchers are looking to immune checkpoint inhibitors plus chemotherapy for recurrent #SmallCellLungCancer. Learn more at https://t.co/oOmZI6jqmf https://t.co/KHV8JDEjHY
-
-
Mashup Score: 17A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - 6 month(s) ago
Learn more about services at Mayo Clinic.
Source: www.mayo.eduCategories: General Medicine News, General HCPsTweet-
Mayo Clinic researchers are looking to immune checkpoint inhibitors plus chemotherapy for recurrent #SmallCellLungCancer. Learn more at https://t.co/8cG775ZuOu https://t.co/Qd0UHG92Ca
-
-
Mashup Score: 4Astrocyte–Tumor Cell Cross-talk Promotes Brain Metastasis of Small Cell Lung Cancer - 7 month(s) ago
Small cell lung cancer (SCLC) cell–astrocyte cross-talk drives a brain development program and SCLC growth.
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Read this week's Cancer Discovery #ResearchWatch: Astrocyte–Tumor Cell Cross-talk Promotes Brain Metastasis of #SmallCellLungCancer, a summary of the paper by Fangfei Qu, @SageJulien et al. https://t.co/PgnHQTI1XR @Stanford #sclc https://t.co/49tfoZ2lRW
-
-
Mashup Score: 3Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation - 10 month(s) ago
A genomic investigation of 3,600 small cell lung cancer (SCLC) tumors reveals novel rare cohorts with potential therapeutic importance, biopsy site–specific heterogeneity, and new insights into SCLC histologic transformation.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
July issue— Integrative Analysis of a Large Real-world Cohort of #SmallCellLungCancer Identifies Distinct Genetic Subtypes & Insights into Histological Transformation, @smruthy90, @SageJulien, @christine_lovly et al. https://t.co/SezbqmNMIx @FoundationATCG @Stanford @VUMC_Cancer https://t.co/W9HwPSODX5
-
-
Mashup Score: 2
Abstract. Small cell lung cancer (SCLC) is a recalcitrant neuroendocrine carcinoma with dismal survival outcomes. A major barrier in the field has been the relative paucity of human tumors studied. Here we provide an integrated analysis of 3,600 “real-world” SCLC cases. This large cohort allowed us to identify new recurrent alterations and genetic subtypes, including STK11-mutant tumors (1.7%)…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI— Published during #AACR23. Genetic subtypes of SCLC tied to clinical outcomes— by @smruthy90, @SageJulien, @christine_lovly et al. https://t.co/ILVFP3fIAu @FoundationATCG @Stanford @VUMC_Cancer @OncoAlert #SmallCellLungCancer https://t.co/13dQk2GwJn
-
-
Mashup Score: 0
Abstract. Small cell lung cancer (SCLC) is a recalcitrant neuroendocrine carcinoma with dismal survival outcomes. A major barrier in the field has been the relative paucity of human tumors studied. Here we provide an integrated analysis of 3,600 “real-world” SCLC cases. This large cohort allowed us to identify new recurrent alterations and genetic subtypes, including STK11-mutant tumors (1.7%)…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Integrative Analysis of a Large Real-world Cohort of #SmallCellLungCancer Identifies Distinct Genetic Subtypes and Insights into Histological Transformation— by @smruthy90, @SageJulien, @christine_lovly et al. https://t.co/59eYVFFOzF @FoundationATCG @Stanford @VUMC_Cancer https://t.co/1khnk5hkAg
-
-
Mashup Score: 0Outcomes after first-line therapy for small cell lung cancer may vary by trial eligibility - 1 year(s) ago
Overall treatment outcomes among patients with extensive-stage small cell lung cancer who received first-line chemoimmunotherapy appeared comparable to those reported in pivotal clinical trials, according to study results.However, outcomes after chemoimmunotherapy may differ between those who meet eligibility criteria for pivotal clinical trials and those who do not, researchers concluded.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Outcomes after first-line therapy for small cell lung cancer may vary by trial eligibility. https://t.co/wOrBOyCJ3t #smallcellLungCancer #LungCancer #HemOnc #OncAlert #MedEd
-
-
Mashup Score: 0
Patients with limited-stage small cell lung cancer who received higher-dose, once-daily radiotherapy achieved outcomes comparable to those who received the standard lower-dose, once-daily regimen, according to phase 3 study results. The findings suggest physicians now have two equal options to discuss with their patients, researchers concluded.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Patients with small cell lung cancer have ‘real choice’ in radiotherapy regimen. https://t.co/A8gFlY8RNQ @UpstateNews #lungcancer #smallcelllungcancer #HemOnc #OncAlert #MedEd
-
NOW ONLINE Here, the authors investigated the utility of liquid biopsy analysis of circulating tumor cells #SmallCellLungCancer 🔓OPEN ACCESS ➡️https://t.co/jJ2WH2Ccr4 @OliverIllini https://t.co/PUMGSDnZWo